192 related articles for article (PubMed ID: 33731694)
1. Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2.
Wang S; Wang Z; Li J; Qin J; Song J; Li Y; Zhao L; Zhang X; Guo H; Shao C; Kong B; Liu Z
Cell Death Dis; 2021 Mar; 12(4):294. PubMed ID: 33731694
[TBL] [Abstract][Full Text] [Related]
2. The Deubiquitinase USP39 Promotes Esophageal Squamous Cell Carcinoma Malignancy as a Splicing Factor.
Zhu X; Ma J; Lu M; Liu Z; Sun Y; Chen H
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627203
[TBL] [Abstract][Full Text] [Related]
3. USP39 promotes ovarian cancer malignant phenotypes and carboplatin chemoresistance.
Wang L; Chen T; Li X; Yan W; Lou Y; Liu Z; Chen H; Cui Z
Int J Oncol; 2019 Jul; 55(1):277-288. PubMed ID: 31180526
[TBL] [Abstract][Full Text] [Related]
4. The splicing factor WBP11 mediates MCM7 intron retention to promote the malignant progression of ovarian cancer.
Wei Y; Chen Z; Li Y; Song K
Oncogene; 2024 May; 43(20):1565-1578. PubMed ID: 38561505
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-specific peptidase 39 regulates the process of proliferation and migration of human ovarian cancer via p53/p21 pathway and EMT.
Yan C; Yuan J; Xu J; Zhang G; Li X; Zhang B; Hu T; Huang X; Mao Y; Song G
Med Oncol; 2019 Oct; 36(11):95. PubMed ID: 31637536
[TBL] [Abstract][Full Text] [Related]
6. The Deubiquitinase USP39 Promotes ESCC Tumorigenesis Through Pre-mRNA Splicing of the mTORC2 Component Rictor.
Zhao Y; Geng H; Liu G; Ji Q; Cheng X; Li X; Liu W; Thorne RF; Zhang R; Liu X
Front Oncol; 2021; 11():667495. PubMed ID: 34123832
[TBL] [Abstract][Full Text] [Related]
7. HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes.
Wu J; Liu Z; Shao C; Gong Y; Hernando E; Lee P; Narita M; Muller W; Liu J; Wei JJ
Cancer Res; 2011 Jan; 71(2):349-59. PubMed ID: 21224353
[TBL] [Abstract][Full Text] [Related]
8. MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2.
Tian X; Song J; Zhang X; Yan M; Wang S; Wang Y; Xu L; Zhao L; Wei JJ; Shao C; Kong B; Liu Z
Cell Death Dis; 2020 Mar; 11(3):167. PubMed ID: 32127525
[TBL] [Abstract][Full Text] [Related]
9. RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation.
Ding K; Ji J; Zhang X; Huang B; Chen A; Zhang D; Li X; Wang X; Wang J
Oncogene; 2019 Sep; 38(37):6414-6428. PubMed ID: 31332287
[TBL] [Abstract][Full Text] [Related]
10. USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC.
Zheng J; Wu S; Tang M; Xi S; Wang Y; Ren J; Luo H; Hu P; Sun L; Du Y; Yang H; Wang F; Gao H; Dai Z; Ou X; Li Y
Cell Death Dis; 2023 Oct; 14(10):670. PubMed ID: 37821439
[TBL] [Abstract][Full Text] [Related]
11. Spliceosome-associated factor CTNNBL1 promotes proliferation and invasion in ovarian cancer.
Li Y; Guo H; Jin C; Qiu C; Gao M; Zhang L; Liu Z; Kong B
Exp Cell Res; 2017 Aug; 357(1):124-134. PubMed ID: 28501461
[TBL] [Abstract][Full Text] [Related]
12. USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo.
Yuan X; Sun X; Shi X; Jiang C; Yu D; Zhang W; Guan W; Zhou J; Wu Y; Qiu Y; Ding Y
Oncol Rep; 2015 Aug; 34(2):823-32. PubMed ID: 26081192
[TBL] [Abstract][Full Text] [Related]
13. MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2.
Xing F; Song Z; He Y
Biol Res; 2018 Nov; 51(1):50. PubMed ID: 30474570
[TBL] [Abstract][Full Text] [Related]
14. USP39 Deubiquitinase Is Essential for
Fraile JM; Manchado E; Lujambio A; Quesada V; Campos-Iglesias D; Webb TR; Lowe SW; López-Otín C; Freije JM
J Biol Chem; 2017 Mar; 292(10):4164-4175. PubMed ID: 28154181
[No Abstract] [Full Text] [Related]
15. BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition.
Han W; Zhang Y; Niu C; Guo J; Li J; Wei X; Jia M; Zhi X; Yao L; Meng D
Cancer Lett; 2019 Mar; 445():45-56. PubMed ID: 30654010
[TBL] [Abstract][Full Text] [Related]
16. The splicing factor SNRPB promotes ovarian cancer progression through regulating aberrant exon skipping of POLA1 and BRCA2.
Li Y; Chen Z; Peng J; Yuan C; Yan S; Yang N; Li P; Kong B
Oncogene; 2023 Jul; 42(31):2386-2401. PubMed ID: 37391593
[TBL] [Abstract][Full Text] [Related]
17. An NAD
Dong L; Yu L; Li H; Shi L; Luo Z; Zhao H; Liu Z; Yin G; Yan X; Lin Z
iScience; 2020 Aug; 23(8):101351. PubMed ID: 32711345
[TBL] [Abstract][Full Text] [Related]
18. HMGA2 gene is a promising target for ovarian cancer silencing therapy.
Malek A; Bakhidze E; Noske A; Sers C; Aigner A; Schäfer R; Tchernitsa O
Int J Cancer; 2008 Jul; 123(2):348-356. PubMed ID: 18452175
[TBL] [Abstract][Full Text] [Related]
19. Spliceosome component Usp39 contributes to hepatic lipid homeostasis through the regulation of autophagy.
Cui D; Wang Z; Dang Q; Wang J; Qin J; Song J; Zhai X; Zhou Y; Zhao L; Lu G; Liu H; Liu G; Liu R; Shao C; Zhang X; Liu Z
Nat Commun; 2023 Nov; 14(1):7032. PubMed ID: 37923718
[TBL] [Abstract][Full Text] [Related]
20. Effects of HMGA2 on malignant degree, invasion, metastasis, proliferation and cellular morphology of ovarian cancer cells.
Xi YN; Xin XY; Ye HM
Asian Pac J Trop Med; 2014 Apr; 7(4):289-92. PubMed ID: 24507678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]